499 top medical experts on Creutzfeldt-Jakob Syndrome across 35 countries and 23 U.S. states, including 341 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Creutzfeldt-Jakob Syndrome: A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ataxia; aphasia, visual loss, weakness, muscle atrophy, myoclonus, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with encephalopathy, bovine spongiform) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of prions. (From N Engl J Med, 1998 Dec 31;339(27))
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Dementia (5,282), Prion Diseases (1,314).
  4. Clinical Trials ClinicalTrials.gov : at least 5 including 3 Completed, 1 Recruiting
  5. Synonyms: New Variant Creutzfeldt-Jakob Disease,  Subacute Spongiform Encephalopathy


  

        

                    


    Computing Expert Listing ...

);